Applications

1665 – Radiofrequency echographic multi spectrometry for bone density measurement and determination of osteopenia/osteoporosis

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation Closed
  • Pre-MSAC consultation Closed
  • Outcome Not supported

Application details

Reason for application

New MBS item.

Service or technology in this application

Radiofrequency Echographic Multi Spectrometry (REMS) is a non-invasive ultrasound method for evaluation of bone mineral density (BMD) at the lumbar vertebrae L1-L4 (lower spine) and the femoral neck (upper thigh bone connecting to the hip joint). REMS is used to diagnose osteoporosis, providing the standard parameters used in diagnosis such as BMD, T-score and Z-score.

Type: Investigative technology

Medical condition this application addresses

Osteoporosis is a condition where bones become thin, weak and fragile, such that even a minor bump or accident can cause a broken bone (minimal trauma fracture). Examples of such events might include falling out of a bed or chair, or tripping and falling while walking. Osteopenia is a condition when bone mineral density is lower than normal but not low enough to be classified as osteoporosis. Fractures due to osteoporosis can result in chronic pain, disability, loss of independence and premature death.

Consultation survey and deadlines

  • PASC consultation: Closed
  • MSAC consultation: Closed Friday 10 June 2022

Meetings to consider this application

  • PASC meeting: 9 to 10 December 2021
  • ESC meeting: 9 to 10 June 2022
  • MSAC meeting: 28 to 29 July 2022